RNA Avidity Biosciences
- 30.500
- -0.290-0.94%
Avidity Biosciences News
Avidity Biosciences | 8-K: Current report
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Flanagan W. Michael
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer MacLean Michael F
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Boyce Sarah
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Teresa
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Teresa
Avidity Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Flanagan W. Michael
Avidity Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Teresa
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Director LEVIN ARTHUR A
Avidity Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(5.4%),Peter Kolchinsky(5.4%), etc.
Avidity Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.0%)
Avidity Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(8.3%),Behzad Aghazadeh(8.3%)
Avidity Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(0%)
Avidity Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bristol-Myers Squibb Company(4.3%)
Avidity Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.84%)
Avidity Biosciences | 8-K: Current report
Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer MacLean Michael F
Avidity Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Management Group LLP(5.97%),Wellington Group Holdings LLP(5.97%), etc.
No Data